Back to search

Article

A bioengineered immunocompetent human leukemia chip for preclinical screening of CAR T cell immunotherapy

2023-04-21

Abstract excerpt

<title>Abstract</title> <p>Chimeric antigen receptor (CAR) T cell immunotherapy is promising for treatment of blood cancers; however, clinical benefits remain unpredictable, necessitating development of optimal CAR T cell products. Unfortunately, current preclinical evaluation platforms are inadequate due to their limited physiological relevance to humans. We herein engineered an organotypic immunocompetent chip...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b6ac7f5b-8702-5236-b9c5-11f46e51299b
DOI
10.21203/rs.3.rs-2762929/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A bioengineered immunocompetent human leukemia chip for preclinical screening of CAR T cell immunotherapyDOI 10.21203/rs.3.rs-2762929/v1
Select a neighboring publication to make it the new centre.